Join PanCAN on Thursday, March 26, at 11 a.m. PT / 2 p.m. ET, for our Nutrition Month webinar. Our panel of special guests will talk about common nutritional challenges as well as leading-edge ...
Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer.
Editor’s Note: Michigan PurpleStride Chair Renee Clearman spoke with Community Engagement Senior Specialist Paula Mukherjee about her passion for PanCAN’s mission and excitement for PanCAN ...
Estos son algunos consejos y opciones de alimentos para diabéticos que les ayudarán a satisfacer sus necesidades ...
Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...
In the coming year, more people than ever before are expected to be diagnosed with pancreatic cancer. And with a five-year survival rate that continues to hover at 13%, this cancer remains one of the ...
Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...
This Pancreatic Cancer Awareness Month, PanCAN is inviting you to shine a light on pancreatic cancer. Let’s uplift survivors and those living with the disease, honor the lives we’ve lost and help ...
Recently, representing PanCAN Patient Services as our manager of research and education communication, I joined a group of patient advocates and researchers in Cambridge, UK, for an annual symposium ...
LOS ANGELES, CALIF. – (July 2, 2025) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to fighting pancreatic cancer, today announced a new data partnership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results